The post-thrombotic syndrome (PTS), which refers to chronic clinical manifestations of
venous insufficiency after a deep vein thrombosis (DVT), is a frequent occurrence. Because …

Background: Risk factors for post‐thrombotic syndrome (PTS) remain poorly understood.
Objectives: In this multinational multicenter study, we evaluated whether subtherapeutic …

Background The appropriate duration of oral anticoagulation after a first episode of venous
thromboembolism (VTE) is uncertain and depends upon VTE recurrence rates. Objective To …

Background: The long-term risk for fatal pulmonary embolism (PE) after treatment of venous
thromboembolism (VTE) may be an important factor in the decision to discontinue this …

Venous thromboembolism (VTE) remains a widespread clinical problem associated with
significant morbidity and mortality. It is estimated that VTE results in 300,000 to 600,000 …

Thieme E-Journals - Seminars in Vascular Medicine / Full Text DE EN Home Products
Journals Books Book Series Service Library Service Help Contact Portal Seminars in Vascular …

Introduction Post-thrombotic syndrome (PTS) is a chronic complication of deep vein
thrombosis (DVT) that affects 20% to 50% of DVT patients. Standard DVT treatment included …

Recurrent VTE after discontinuing anticoagulation occurs with surprising frequency.
Observational studies from Mayo Clinic's Olmsted County, Minnesota, 8 and Padua, Italy, 9 …

Introduction VTE‐BLEED is a validated score for identification of patients at increased risk of
major bleeding during extended anticoagulation for venous thromboembolism (VTE). It is …

Despite considerable advances in the identification of new risk factors for VTE, predicting the
risk of recurrence in an individual patient remains a challenge. The impact of many of these …